about
An update on Acanthamoeba keratitis: diagnosis, pathogenesis and treatmentAmoebicidal efficiencies of various diamidines against two strains of Acanthamoeba polyphagaIn vitro amoebicidal activity of four Allium species on Acanthamoeba castellanii and their cytotoxic potentials on corneal cells.In vitro effectiveness of Thymus sipyleus subsp. sipyleus var. sipyleus on Acanthamoeba castellanii and its cytotoxic potential on corneal cells.Confirmatory evidence from 18S rRNA gene analysis for in vivo development of propamidine resistance in a temporal series of Acanthamoeba ocular isolates from a patient.Failure of chemotherapy in the first reported cases of Acanthamoeba keratitis in Pakistan.In vitro amoebicidal activity of four Peucedanum species on Acanthamoeba castellanii cysts and trophozoites.Acanthamoeba-cytopathic protein induces apoptosis and proinflammatory cytokines in human corneal epithelial cells by cPLA2α activation.Acanthamoeba spp. as agents of disease in humansAcanthamoeba keratitis update-incidence, molecular epidemiology and new drugs for treatment.Gold Nanoparticle Conjugation Enhances the Antiacanthamoebic Effects of Chlorhexidine.A Review of the Current Research Trends in the Application of Medicinal Plants as a Source for Novel Therapeutic Agents Against Acanthamoeba Infections.Photochemotherapeutic strategy against Acanthamoeba infections.Miltefosine and polyhexamethylene biguanide: a new drug combination for the treatment of Acanthamoeba keratitis.Artemisia annua L. as a plant with potential use in the treatment of acanthamoebiasis.Acanthamoeba keratitis.Cytotoxic activities of alkylphosphocholines against clinical isolates of Acanthamoeba spp.A review of 72 consecutive cases of Acanthamoeba keratitis, 1984-1992.Photochemotherapeutic strategies against Acanthamoeba keratitis.Cytotoxic activity of N-chlorotaurine on Acanthamoeba sppThe effects of phosphanegold(I) thiolates on the biological properties of Acanthamoeba castellanii belonging to the T4 genotypePersistent acanthamoeba keratitis in a non-contact lens wearer following exposure to bird seed dust.Perioperative treatment and prognostic factors for penetrating keratoplasty in Acanthamoeba keratitis unresponsive to medical treatment.Plant extracts as natural amoebicidal agents.Acanthamoebicidal activity of Fusarium sp. Tlau3, an endophytic fungus from Thunbergia laurifolia Lindl.Anti-amoebic properties of carbonyl thiourea derivatives.The effect of propolis in experimental Acanthamoeba keratitis.Molecular and physiological evaluation of subtropical environmental isolates of Acanthamoeba spp., causal agent of Acanthamoeba keratitis.Efficacy of miltefosine for topical treatment of Acanthamoeba keratitis in Syrian hamsters.Microbial keratitis--the false negative.Evaluation of the activity of new cationic carbosilane dendrimers on trophozoites and cysts of Acanthamoeba polyphaga.In-vitro Activity of Trigonella foenum graecum Seeds Against a Clinical Strain of Acanthamoeba Genotype T4.
P2860
Q22812999-F89B1472-1F4C-4157-BA12-F93E748C901AQ24678699-9D707E2F-3969-4ADB-A378-43F4BB832567Q33275217-1018C15A-C017-4345-9B28-693C31D00279Q33292185-8D7302C9-EAEF-496C-A50B-58B421E9F84FQ33698733-62E3F420-4BE5-4D13-8A1A-D71364CD5001Q33850855-689429B9-CC57-4BD7-A9DE-9823FDE69B89Q33916993-AD31B9A7-9960-42A0-A6D5-3A4478C0B6FAQ33961127-D84F6300-B080-4373-9D7F-F80A256B978DQ34190211-9A9CCD9A-BC43-4E9F-A508-B9C0E52BA183Q35590391-B6F6B894-F265-4FEC-892B-BB0FF6B7A7E9Q35868588-54FC3C4A-C1AD-4F82-937D-CFC0E58EA239Q37651145-625A723D-BEB4-4603-B1F4-B3AE9C5BA136Q38901985-E6B82CB1-CB9F-48F1-B78E-CDA5C170FDDFQ39163677-3D1CB3D5-FEC3-4525-9221-6D2004B54559Q39197765-9AB6B393-352A-4A97-9590-B7BAF3F83414Q39612485-7715DC39-1267-4CF4-B5CE-F5084E35A7BDQ39653044-94986B0A-8EA1-47F1-864C-E004FE64104CQ40720490-568F18EA-F536-4CFE-92E2-03C7C0DD2BA6Q41198501-DD5C959E-E1D1-4977-81D9-C46E0AD965A9Q41915150-B79FC040-A151-4A15-9C4D-A36664932CF9Q42121467-3D345F3B-3BB4-48A5-A6A2-2A13C073C6F4Q42923137-1F43EC49-92CF-4FEF-9D25-8CDB40DEAEEEQ43415699-94C16335-FB00-48CF-8770-80A9F39CBD30Q46218205-79C760D9-266D-4145-88D2-924D8225E575Q46479037-C1638B73-1E36-42CC-B493-99B159DE0EBBQ46902385-F7CEEE1B-8929-43AE-A890-7226DAF250B1Q46903667-AA529F5A-BF2E-4ADE-B1F3-0EE7EDC8C4A2Q48191641-2C2E6C91-7F77-45D5-82F3-E28853B13103Q51766684-25A52BD0-10AE-4BFF-AF1E-406200C05797Q52464062-3BF9FA9E-7DD7-4A76-AE59-05726545DD4EQ52654699-467B1F80-44F7-42CF-86C0-D4FE5FBF7B0FQ54940244-B5A92DA8-4384-44E1-864B-B046F5E0779C
P2860
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh-hant
name
Acanthamoeba keratitis--resistance to medical therapy.
@en
Acanthamoeba keratitis--resistance to medical therapy.
@nl
type
label
Acanthamoeba keratitis--resistance to medical therapy.
@en
Acanthamoeba keratitis--resistance to medical therapy.
@nl
prefLabel
Acanthamoeba keratitis--resistance to medical therapy.
@en
Acanthamoeba keratitis--resistance to medical therapy.
@nl
P2093
P2860
P356
P1433
P1476
Acanthamoeba keratitis--resistance to medical therapy
@en
P2093
P2860
P2888
P304
P356
10.1038/EYE.1990.132
P478
P577
1990-01-01T00:00:00Z